Clinical trial
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced…
NCT00242827 · Cephalon, Industry · Terminated
Key facts
| NCT number | NCT00242827 |
|---|---|
| Title | Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma |
| Official title | An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma |
| Lead sponsor | Cephalon, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myeloma |
| Intervention type | Drug |
| Interventions | Oral CEP-701 |
| Start date | Apr 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Oct 21, 2005 |
| Last update posted | Aug 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: